Victor E Alvarez Selected Research

Chronic Traumatic Encephalopathy

1/2022	Association of APOE Genotypes and Chronic Traumatic Encephalopathy.
1/2022	A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease.
1/2022	MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.
12/2021	Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.
10/2021	Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.
1/2021	A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy.
1/2020	Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy.
1/2018	Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.
1/2017	CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.
1/2017	Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor E Alvarez Research Topics

Disease

14	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2012
13	Chronic Traumatic Encephalopathy 01/2022 - 01/2013
9	Tauopathies 10/2021 - 01/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2012
4	Cognitive Dysfunction 01/2017 - 01/2014
3	Atrophy 12/2021 - 01/2014
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 01/2014
2	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 01/2013
2	Inflammation (Inflammations) 01/2021 - 01/2014
2	Craniocerebral Trauma (Head Injury) 01/2021 - 01/2020
2	Frontotemporal Dementia (Semantic Dementia) 12/2018 - 01/2018
2	Gliosis 12/2018 - 01/2018
2	Neuroinflammatory Diseases 11/2018 - 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Cataract (Cataracts) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Amyloid Plaque 01/2022
1	Neurobehavioral Manifestations 10/2021
1	Hemorrhage 04/2020
1	Body Weight (Weight, Body) 01/2020
1	Corticobasal Degeneration 10/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019
1	Dementia (Dementias) 01/2018
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2018
1	Wounds and Injuries (Trauma) 07/2015
1	Hypertension (High Blood Pressure) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Obesity 01/2014
1	Stroke (Strokes) 01/2014
1	Headache (Headaches) 01/2013

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2012
6	Amyloid (Amyloid Fibrils)IBA 01/2022 - 02/2012
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2012
5	tau Proteins (tau Protein)IBA 01/2018 - 01/2013
4	Amyloid beta-PeptidesIBA 01/2022 - 01/2013
3	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2014 - 01/2013
2	Peptides (Polypeptides)IBA 01/2022 - 07/2015
2	Protein Isoforms (Isoforms)IBA 12/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	N-methyladenosineIBA 10/2021
1	TESIBA 10/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020
1	GadoliniumIBA 01/2020
1	Gadolinium DTPA (Magnevist)FDA Link 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	Protein Kinase CIBA 01/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020
1	RNA Precursors (Precursor, mRNA)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 10/2019
1	InterleukinsIBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 12/2018
1	ElementsIBA 01/2018
1	Detergents (Detergent)IBA 01/2018
1	Cholinergic ReceptorsIBA 01/2018
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018
1	Carisoprodol (Soma)FDA LinkGeneric 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	ProteomeIBA 01/2018
1	Caveolin 1IBA 01/2018
1	Sirtuin 3IBA 01/2018
1	adenylate cyclase 3IBA 01/2018
1	Dopa DecarboxylaseIBA 01/2018
1	EnzymesIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	AntioxidantsIBA 01/2014
1	CholesterolIBA 01/2014
1	alpha-SynucleinIBA 01/2013
1	Prion ProteinsIBA 02/2012
1	SynucleinsIBA 02/2012

Therapy/Procedure

1	Lenses 01/2022
1	Traction 04/2020